development - International Biopharmaceutical Industry

Volume 5 Issue 3

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

There is growing excitement about the potential shown by cell and gene therapies, particularly in rare diseases. First, though, these therapies face challenges both i...

12 October 2022 Volume 5 Issue 3 achieving | advanced

Continue Reading →

Volume 5 Issue 3

Importance of Lyobeads and Using the MicroPress to Determine Quality Metrics

The development of lyophilised products helps reduce the impact of cold chain management from refrigerated warehouses to point use. These products, typically, benefit...

12 October 2022 Volume 5 Issue 3 cold chain | development

Continue Reading →

news

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picod...

2 November 2021 news Antibody | cell screening

Continue Reading →

Volume 4 Issue 3

How to Bring Your Oncolytic Virus Innovation to Market: the Secret to Successful Development

Cancer continues to be a major burden on healthcare systems across the world, with global spending on therapies and supportive care drugs expected to reach $200 billi...

1 September 2021 Volume 4 Issue 3 development | innovation

Continue Reading →

Volume 4 Issue 3

CRISPR-Cas9 Knockout Screening Using Primary Human Cells in Drug Discovery

While significant progress has been made carrying out CRISPR screens in immortalised cell lines, a more physiological and clinically relevant alternative is human pri...

31 August 2021 Volume 4 Issue 3 CRISPR | development

Continue Reading →

Volume 4 Issue 3

Are We Nearly There Yet? The Ongoing Journey of CAR-T Cell Therapies

CAR-T cells have a genetically engineered T-cell receptor (TCR) that directs their binding to cancer cells. In first-generation CARs, the TCR was engineered to expres...

31 August 2021 Volume 4 Issue 3 CAR-T cells | development

Continue Reading →

news

Moxidectin gets USFDA nod to treat River Blindness

Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) have announce...

15 June 2018 news blindness | development

Continue Reading →

news

Fully Supporting Customer Needs for Biologics Development and Manufacturing

Over the past seven years, Samsung BioLogics has constructed three state-of-the-art production facilities offering end-to-end integrated services to support the rapid...

8 May 2018 news biologics | development

Continue Reading →

N-S

Richter-Helm

GERMAN RELIABILITY AND THOROUGHNESS Richter-Helm is a Hamburg, Germany-based contract development and manufacturing company specialized in products derived from bact...

18 April 2018 N-S company | contract

Continue Reading →

Current Edition